Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Menopausal Hormone Therapy and Risk of Diverticulitis.

Jovani M, Ma W, Joshi AD, Liu PH, Nguyen LH, Cao Y, Tam I, Wu K, Giovannucci EL, Chan AT, Strate LL.

Am J Gastroenterol. 2019 Feb;114(2):315-321. doi: 10.14309/ajg.0000000000000054.

PMID:
30730324
2.

Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause.

Staller K, Townsend MK, Khalili H, Mehta R, Grodstein F, Whitehead WE, Matthews CA, Kuo B, Chan AT.

Gastroenterology. 2017 Jun;152(8):1915-1921.e1. doi: 10.1053/j.gastro.2017.02.005. Epub 2017 Feb 14.

3.

Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.

Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault MC.

Am J Clin Nutr. 2015 Oct;102(4):966-73. doi: 10.3945/ajcn.114.104323. Epub 2015 Sep 9.

PMID:
26354532
4.

Hormone therapy increases risk of ulcerative colitis but not Crohn's disease.

Khalili H, Higuchi LM, Ananthakrishnan AN, Manson JE, Feskanich D, Richter JM, Fuchs CS, Chan AT.

Gastroenterology. 2012 Nov;143(5):1199-1206. doi: 10.1053/j.gastro.2012.07.096. Epub 2012 Jul 27.

5.

Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort.

Obi N, Heinz J, Seibold P, Vrieling A, Rudolph A, Chang-Claude J, Berger J, Flesch-Janys D.

Int J Cancer. 2016 May 1;138(9):2098-108. doi: 10.1002/ijc.29951. Epub 2015 Dec 30.

6.

Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.

Cadeau C, Fournier A, Mesrine S, Clavel-Chapelon F, Fagherazzi G, Boutron-Ruault MC.

Int J Cancer. 2016 Nov 15;139(10):2193-200. doi: 10.1002/ijc.30282. Epub 2016 Jul 30.

7.

Association Between Obesity and Weight Change and Risk of Diverticulitis in Women.

Ma W, Jovani M, Liu PH, Nguyen LH, Cao Y, Tam I, Wu K, Giovannucci EL, Strate LL, Chan AT.

Gastroenterology. 2018 Jul;155(1):58-66.e4. doi: 10.1053/j.gastro.2018.03.057. Epub 2018 Apr 1.

PMID:
29614301
8.

Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.

Cervenka I, Al Rahmoun M, Mahamat-Saleh Y, Savoye I, Boutron-Ruault MC, Fournier A, Kvaskoff M.

Int J Cancer. 2019 Jan 22. doi: 10.1002/ijc.32150. [Epub ahead of print]

PMID:
30671928
9.

Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.

Park SY, Wilkens LR, Kolonel LN, Henderson BE, Le Marchand L.

Int J Cancer. 2016 Sep 15;139(6):1241-50. doi: 10.1002/ijc.30172. Epub 2016 May 14.

10.

Menopausal hormone therapy and mortality among women diagnosed with ovarian cancer in the NIH-AARP Diet and Health Study.

Felix AS, Bunch K, Yang HP, Arem H, Trabert B, Gierach GL, Park Y, Lowery WJ, Brinton LA.

Gynecol Oncol Rep. 2015 May 8;13:13-7. doi: 10.1016/j.gore.2015.04.007. eCollection 2015 Aug.

11.

Reproductive factors and menopausal hormone therapy and bladder cancer risk in the NIH-AARP Diet and Health Study.

Daugherty SE, Lacey JV Jr, Pfeiffer RM, Park Y, Hoover RN, Silverman DT.

Int J Cancer. 2013 Jul 15;133(2):462-72. doi: 10.1002/ijc.28022. Epub 2013 Feb 12.

12.

Body fat distribution, menopausal hormone therapy and incident type 2 diabetes in postmenopausal women of the MESA study.

Ebong IA, Watson KE, Hairston KG, Carnethon MR, Ouyang P, Szklo M, Bertoni AG.

Maturitas. 2016 Sep;91:147-52. doi: 10.1016/j.maturitas.2016.06.020. Epub 2016 Jun 28.

13.

Identification of Menopausal and Reproductive Risk Factors for Microscopic Colitis-Results From the Nurses' Health Study.

Burke KE, Ananthakrishnan AN, Lochhead P, Liu PH, Olen O, Ludvigsson JF, Richter JM, Tworoger SS, Chan AT, Khalili H.

Gastroenterology. 2018 Dec;155(6):1764-1775.e2. doi: 10.1053/j.gastro.2018.08.029. Epub 2018 Aug 23.

PMID:
30144433
14.

Reproductive factors and epithelial ovarian cancer survival in the EPIC cohort study.

Bešević J, Gunter MJ, Fortner RT, Tsilidis KK, Weiderpass E, Onland-Moret NC, Dossus L, Tjønneland A, Hansen L, Overvad K, Mesrine S, Baglietto L, Clavel-Chapelon F, Kaaks R, Aleksandrova K, Boeing H, Trichopoulou A, Lagiou P, Bamia C, Masala G, Agnoli C, Tumino R, Ricceri F, Panico S, Bueno-de-Mesquita HB, Peeters PH, Jareid M, Quirós JR, Duell EJ, Sánchez MJ, Larrañaga N, Chirlaque MD, Barricarte A, Dias JA, Sonestedt E, Idahl A, Lundin E, Wareham NJ, Khaw KT, Travis RC, Rinaldi S, Romieu I, Riboli E, Merritt MA.

Br J Cancer. 2015 Dec 1;113(11):1622-31. doi: 10.1038/bjc.2015.377. Epub 2015 Nov 10.

15.

Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.

Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, Hémon B, Rinaldi S, Chajes V, Slimani N, Allen NE, Reeves GK, Bingham S, Khaw KT, Olsen A, Tjønneland A, Rodriguez L, Sánchez MJ, Etxezarreta PA, Ardanaz E, Tormo MJ, Peeters PH, van Gils CH, Steffen A, Schulz M, Chang-Claude J, Kaaks R, Tumino R, Gallo V, Norat T, Riboli E, Panico S, Masala G, González CA, Berrino F.

Int J Cancer. 2011 Jan 1;128(1):144-56. doi: 10.1002/ijc.25314.

16.

Is breast cancer risk the same for all progestogens?

Stute P.

Arch Gynecol Obstet. 2014 Aug;290(2):207-9. doi: 10.1007/s00404-014-3270-0.

PMID:
24838289
17.

Menopausal hormone therapy and mortality among endometrial cancer patients in the NIH-AARP Diet and Health Study.

Felix AS, Arem H, Trabert B, Gierach GL, Park Y, Pfeiffer RM, Brinton LA.

Cancer Causes Control. 2015 Aug;26(8):1055-63. doi: 10.1007/s10552-015-0598-0. Epub 2015 May 12.

18.

Menopause and postmenopausal hormone therapy and risk of hearing loss.

Curhan SG, Eliassen AH, Eavey RD, Wang M, Lin BM, Curhan GC.

Menopause. 2017 Sep;24(9):1049-1056. doi: 10.1097/GME.0000000000000878.

19.

Differences in Parkinson's Disease Risk with Caffeine Intake and Postmenopausal Hormone Use.

Kim IY, O'Reilly ÉJ, Hughes KC, Gao X, Schwarzschild MA, Ascherio A.

J Parkinsons Dis. 2017;7(4):677-684. doi: 10.3233/JPD-171175.

PMID:
28984617
20.

Menopausal hormone therapy and breast cancer: what is the true size of the increased risk?

Jones ME, Schoemaker MJ, Wright L, McFadden E, Griffin J, Thomas D, Hemming J, Wright K, Ashworth A, Swerdlow AJ.

Br J Cancer. 2016 Aug 23;115(5):607-15. doi: 10.1038/bjc.2016.231. Epub 2016 Jul 28.

Supplemental Content

Support Center